Display options
Cite
Bosscher MR, Wentholt IM, Ackermans MT, et al. An adrenal mass and increased catecholamines: monoamine oxidase or pheochromocytoma effect?. J Clin Med Res. 2014;7(3):199-201doi: 10.14740/jocmr2042w.
Bosscher, M. R., Wentholt, I. M., Ackermans, M. T., & Nieveen van Dijkum, E. J. (2015). An adrenal mass and increased catecholamines: monoamine oxidase or pheochromocytoma effect?. Journal of clinical medicine research, 7(3), 199-201. https://doi.org/10.14740/jocmr2042w
Bosscher, Marianne R F, et al. "An adrenal mass and increased catecholamines: monoamine oxidase or pheochromocytoma effect?." Journal of clinical medicine research vol. 7,3 (2015): 199-201. doi: https://doi.org/10.14740/jocmr2042w
Bosscher MR, Wentholt IM, Ackermans MT, Nieveen van Dijkum EJ. An adrenal mass and increased catecholamines: monoamine oxidase or pheochromocytoma effect?. J Clin Med Res. 2015 Mar;7(3):199-201. doi: 10.14740/jocmr2042w. Epub 2014 Dec 29. PMID: 25584109; PMCID: PMC4285070.
Copy Download .nbib Format: NLM
Share it on

J Clin Med Res. 2015 Mar;7(3):199-201. doi: 10.14740/jocmr2042w. Epub 2014 Dec 29.

An adrenal mass and increased catecholamines: monoamine oxidase or pheochromocytoma effect?.

Journal of clinical medicine research

Marianne R F Bosscher, Iris M Wentholt, Mariette T Ackermans, Els J M Nieveen van Dijkum

Affiliations

  1. Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  2. Department of Internal Medicine and Endocrinology, Amphia Medical Hospital, Breda, The Netherlands.
  3. Department of Clinical Chemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

PMID: 25584109 PMCID: PMC4285070 DOI: 10.14740/jocmr2042w

Abstract

Hormonal evaluation in patients with an adrenal incidentaloma can be difficult in patients with comorbidities or in patients using interfering drugs. We present a case of a 54-year-old man who was evaluated for an adrenal mass. The medical history reported treatment with a monoamine oxidase (MAO) inhibitor for recurrent psychoses. Hormonal screening showed elevated levels of normetanephrine and metanephrine in plasma and urine, suggesting a diagnosis of pheochromocytoma (PHEO), and an adrenalectomy was performed. Histologic examination showed that the tumor had an origin of the adrenal cortex. MAO inhibitors are also known to cause elevated levels of catecholamines. In this case, a PHEO seemed more likely the cause due to repeatedly elevated levels of metanephrines and normal levels of catecholamines. Since the tumor had an origin of the adrenal cortex, the use of MAO inhibitors was the most likely explanation for the elevated levels of metanephrines. This case illustrated the difficulties in diagnosing PHEO, especially in patients with comorbidities and interfering drugs.

Keywords: Hormonal screening; MAO inhibitor; Pheochromocytoma; Pseudopheochromocytoma

References

  1. Horm Metab Res. 2009 Sep;41(9):658-63 - PubMed
  2. J Clin Pathol. 2010 Aug;63(8):669-74 - PubMed
  3. NIH Consens State Sci Statements. 2002 Feb 4-6;19(2):1-25 - PubMed
  4. Arch Surg. 2010 Sep;145(9):893-7 - PubMed
  5. J Clin Endocrinol Metab. 1995 Oct;80(10):3009-17 - PubMed
  6. Neuropsychiatr Dis Treat. 2010 Sep 07;6:343-64 - PubMed
  7. Lancet. 1993 Feb 27;341(8844):555-6 - PubMed
  8. Lancet. 1963 Oct 26;2(7313):849-50 - PubMed
  9. Drug Saf. 2007;30(11):1031-62 - PubMed
  10. J Hypertens. 2007 Nov;25(11):2204-6 - PubMed
  11. J Clin Endocrinol Metab. 2003 Oct;88(10):4533-9 - PubMed
  12. Eur J Pharmacol. 2010 Jul 10;637(1-3):77-82 - PubMed
  13. J Clin Endocrinol Metab. 1998 Jun;83(6):2175-85 - PubMed
  14. BMJ. 1990 Mar 3;300(6724):614 - PubMed
  15. J Hypertens. 1998 Oct;16(10):1531-7 - PubMed
  16. Am J Surg. 1985 Jun;149(6):783-8 - PubMed

Publication Types